PROGYNY INC
PGNYNASDAQ🏆 #2003 by market capEarnings Oct 29US Equity
$24.47▼ $1.00 (−4.10%)
LiveTrack PGNY
Get earnings, price moves & breaking news on Telegram
24h▼ 4.1%
7d▼ 6.7%
14d▼ 11.9%
30d▼ 5.9%
ytd▼ 4.7%
1y▲ 14.3%
🏦Market Cap
$1.92B
Small Cap
📈Revenue Growth (YoY)
+10.4%
Healthy
📊Gross Margin
24.6%
Moderate
💵FCF Margin
16.6%
Healthy
⚖️P/S Ratio
1.5x
Cheap
Otter Score
72
Fair
PROGYNY INC
PGNYAnalyst Ratings
Price
$24.47
Total
20
Raised
1
Lowered
3
Avg PT
$35.50
H / L
$40 / $30
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citizens | Reiterated | Market Outperform | 2026-09-08 | — | — |
JP Morgan | Reiterated | Neutral | 2026-08-21 | $35.00 | +43.00% |
Truist Securities | Reiterated | Buy | 2026-08-13 | — | — |
Barclays | Reiterated | Equal Weight | 2026-08-12 | $30.00 | +22.60% |
BTIG | Reiterated | Buy | 2026-07-24 | $40.00 | +63.40% |
Canaccord Genuity | Reiterated | Buy | 2026-07-21 | $35.00 | +43.00% |
Keybanc | Reiterated | Overweight | 2026-07-13 | $35.00 | +43.00% |
B of A Securities | Reiterated | Buy | 2026-06-02 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2025-08-08 | $22.00 | −10.10% |
Leerink Partners | Upgraded | Market Perform → Outperform | 2025-07-08 | $38.00 | +55.30% |
JMP Securities | Downgraded | Market Outperform → Market Perform | 2024-09-19 | $36.00 | +47.10% |
Jefferies | Reiterated | Buy | 2024-09-19 | $33.00 | +34.80% |
SVB Leerink | Downgraded | Outperform → Market Perform | 2023-01-05 | — | — |
Berenberg | Reiterated | Buy | 2021-09-30 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2021-06-02 | — | — |
Citigroup | Reiterated | Buy | 2020-08-06 | — | — |
Piper Sandler | Reiterated | Overweight | 2020-08-06 | — | — |
Bank of America | Reiterated | Neutral | 2019-12-04 | — | — |
Citi | Reiterated | Buy | 2019-11-19 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-11-19 | — | — |
Institution
Citizens
Reiterated · Market Outperform · 2026-09-08
—
—
JP Morgan
Reiterated · Neutral · 2026-08-21
$35.00
+43.00%
Truist Securities
Reiterated · Buy · 2026-08-13
—
—
Barclays
Reiterated · Equal Weight · 2026-08-12
$30.00
+22.60%
BTIG
Reiterated · Buy · 2026-07-24
$40.00
+63.40%
Canaccord Genuity
Reiterated · Buy · 2026-07-21
$35.00
+43.00%
Keybanc
Reiterated · Overweight · 2026-07-13
$35.00
+43.00%
B of A Securities
Reiterated · Buy · 2026-06-02
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2025-08-08
$22.00
−10.10%
Leerink Partners
Upgraded · Market Perform → Outperform · 2025-07-08
$38.00
+55.30%
JMP Securities
Downgraded · Market Outperform → Market Perform · 2024-09-19
$36.00
+47.10%
Jefferies
Reiterated · Buy · 2024-09-19
$33.00
+34.80%
SVB Leerink
Downgraded · Outperform → Market Perform · 2023-01-05
—
—
Berenberg
Reiterated · Buy · 2021-09-30
—
—
Guggenheim
Downgraded · Buy → Neutral · 2021-06-02
—
—
Citigroup
Reiterated · Buy · 2020-08-06
—
—
Piper Sandler
Reiterated · Overweight · 2020-08-06
—
—
Bank of America
Reiterated · Neutral · 2019-12-04
—
—
Citi
Reiterated · Buy · 2019-11-19
—
—
Piper Jaffray
Reiterated · Overweight · 2019-11-19
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space